When Cathie Wood’s ARK Invest adds stocks to its portfolio, it tends to catch attention. Wood is not your typical Wall Street investor; her strategy is based on strong conviction, disruptive innovation, and long-term horizons. She is well-known for funding groundbreaking ideas in artificial intelligence (AI), genomics, robotics, energy storage, blockchain, and other "next-gen" technologies that many others regard as too risky or speculative.
On Sept. 10, Wood added Rubrik (RBRK) and Prime Medicine (PRME) to her portfolio. But Wood isn’t known to buy blindly. There are several compelling reasons why Rubrik and Prime Medicine piqued her interest. Let us see if these two growth stocks are worth the investment.
